![Guido Maertens](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Guido Maertens is the founder of Enzyre BV.
Former jobs include Controller at Pharming Group NV, Chief Financial Officer at ACS Biomarker BV, and Finance Consultant at First Dutch Capital BV.
Education includes a graduate degree from the University of Tilburg.
| Companies | Position | End |
|---|---|---|
Enzyre BV
 Enzyre BV Packaged SoftwareTechnology Services Develops biochip platform that enzymatic reactions can be measured | Chief Executive Officer | 2019-04-29 |
First Dutch Capital BV
 First Dutch Capital BV Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | - |
| PHARMING GROUP N.V. | Comptroller/Controller/Auditor | - |
ACS Biomarker BV
 ACS Biomarker BV Medical SpecialtiesHealth Technology Develops and commercializes cardiovascular biomarkers | Director of Finance/CFO | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
University of Tilburg
 University of Tilburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ACS Biomarker BV
ACS Biomarker BV Medical SpecialtiesHealth Technology Develops and commercializes cardiovascular biomarkers | Health Technology |
First Dutch Capital BV
First Dutch Capital BV Investment ManagersFinance Provides investment advice | Finance |
Enzyre BV
Enzyre BV Packaged SoftwareTechnology Services Develops biochip platform that enzymatic reactions can be measured | Technology Services |
Select your edition
All financial news and data tailored to specific country editions
